ArticleFrontiers in immunology2023

Corrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.

Zhimin Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.